Family Medicine Doctors in Box Elder, MT Accepting Medicare
2 Family Medicine doctors found. Showing 1 - 2
 Dr. David Anthony Stock, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 96 Clinic Rd N, Box Elder, MT 59521 Phone: 406-395-4486 Fax: 406-395-4138 |
 Claire Elizabeth Arment, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 96 Clinic Rd N, Box Elder, MT 59521 Phone: 406-395-4486 Fax: 406-395-4138 |
News Archive
Low vitamin D levels: Not a cause but a consequence of ill health
A comprehensive review of the evidence suggests that low vitamin D levels are not a cause but a consequence of ill health, casting strong doubt on the value of vitamin D supplements to protect against acute and chronic disorders such as cancer, cardiovascular disease, diabetes, Parkinson's disease, and even death.
HIV linked to increased risk of end-stage renal disease in African-Americans
For African Americans infected with HIV, the risk of end-stage renal disease (ESRD) is six times higher than for whites with HIV - and similar to the ESRD risk associated with diabetes, reports a study in the November Journal of the American Society of Nephrology.
Experts to present research on prevention, management of dysphagia at international conference
Over 800 delegates from 46 countries will attend the 8th annual European Society for Swallowing Disorders Congress taking place in Dublin next week to hear about new developments in swallowing disorder research.
Study warns against use of bone morphogenetic proteins in pediatric spinal fusion
Bone morphogenetic proteins, commonly used off-label to enhance pediatric spinal fusion (spinal arthrodesis), did not improve revision rates for pediatric spinal fusion, according to a study presented on March 14 at the American Academy of Orthopaedic Surgeons Annual Meeting in San Diego.
Daiichi Sankyo initiates Phase III trial of edoxaban in reducing recurrent VTE complications
Daiichi Sankyo Company, Limited, announced today that it has initiated a new large-scale pivotal Phase III trial for edoxaban, its investigational oral Factor Xa inhibitor. This new study, called HOKUSAI (pronounced hoe·koo·sigh) VTE, is evaluating the safety and efficacy of edoxaban in reducing recurrent venous thromboembolic (VTE) complications in patients with deep vein thrombosis (DVT) and/or pulmonary embolism (PE).
› Verified 5 days ago